...
机译:C-ERBB-2,P53和Caspase-3在不同年龄组中乳腺癌组织中C-ERBB-2,P53和Caspase-3的显着性和表达
Tangshan Matern &
Child Hlth Care Hosp Dept Breast Surg 14 South Jianshe Rd Tangshan 063000;
Tangshan Matern &
Child Hlth Care Hosp Dept Breast Surg 14 South Jianshe Rd Tangshan 063000;
Tangshan Matern &
Child Hlth Care Hosp Dept Breast Surg 14 South Jianshe Rd Tangshan 063000;
Tangshan Matern &
Child Hlth Care Hosp Dept Pathol Tangshan Peoples R China;
Tangshan Matern &
Child Hlth Care Hosp Dept Pathol Tangshan Peoples R China;
Tangshan Matern &
Child Hlth Care Hosp Dept Pathol Tangshan Peoples R China;
Tangshan Matern &
Child Hlth Care Hosp Dept Pathol Tangshan Peoples R China;
Tangshan Matern &
Child Hlth Care Hosp Dept Breast Surg 14 South Jianshe Rd Tangshan 063000;
Breast cancer; Apoptotic factor; Immunohistochemical assay; Prognosis;
机译:C-ERBB-2,P53和Caspase-3在不同年龄组中乳腺癌组织中C-ERBB-2,P53和Caspase-3的显着性和表达
机译:Survivin,p53和C-erbB-2突变在乳腺癌中的表达及其临床意义
机译:Survivin,p53和C-erbB-2突变在乳腺癌中的表达及其临床意义
机译:CD151,整合素α3β1和MMP7在乳腺癌组织微阵列中的表达及其临床病理意义
机译:p53表达和乳腺癌的危险因素。
机译:乳腺癌预后的分子生物标志物:c-erbB-2和p53的共表达
机译:阴性腋窝乳腺癌预后指标:雌激素受体和p53和c-erbB-2表达节点阴性乳腺癌预后指标:雌激素受体和p53和c-erbB-2蛋白表达
机译:队列研究c-erbB-2和细胞周期蛋白D1过表达,p53突变和/或蛋白质积累,以及从良性乳腺疾病进展到乳腺癌的风险;和创建良性乳腺组织